Biotech Affimed Provides Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at the ASH 2022 Annual Meeting December 10, 2022
Biotech EIGR INVESTOR NEWS: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 9, 2022
Health SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – VVNT, SAL, GRAY, APEN December 9, 2022
Cannabis Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against NewAge, Inc. (NBEV) (NBEVQ) December 9, 2022
Biotech Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022 December 9, 2022
Energy Evolve Transition Infrastructure Receives Notice from NYSE American Regarding Continued Listing Standard December 9, 2022
Biotech ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares December 9, 2022
Biotech CLASS ACTION UPDATE for EIGR, CURV and IREN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 9, 2022
Cannabis ROSEN, A LEADING NATIONAL FIRM, Encourages NewAge Inc. Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm – NBEV, NBEVQ December 9, 2022